If you or a loved one experienced eye problems including vision loss or blindness after receiving eye treatment with Beovu, you may be entitled to substantial compensation. Contact the Kishish Law Group now for your free and confidential case evaluation by calling us toll free at 1 (888) 609-4664 or by completing our online contact form.
The U.S. Food and Drug Administration (FDA) has approved a change to the label of Beovu (brolucizumab), a drug prescribed for age-related macular degeneration. Shortly after the approval of Beovu, the FDA and the American Society of Retina Specialists began to receive reports of inflammation after patients took the drug. After investigation, the FDA updated the label of Beovu, warning of previously undisclosed side effects.
Patients are now pursuing legal action against Novartis, the manufacturer of Beovu. Pharmaceutical companies have a duty to fully test their drugs and disclose known side effects to the public. Lawsuits filed by patients may allege that Novartis failed to adequately warn patients of the potential side effects of receiving Beovu treatment or that Novartis could have designed a safer drug. If you or a loved one experienced problems after being prescribed Beovu, you may be able to participate in these lawsuits. Filing a lawsuit can help pay for medical expenses, lost wages, and other kinds of pain and suffering associated with Beovu treatment. And lawsuits can help hold pharmaceutical companies responsible when they fail to make sure their drugs are safe.
What is Beovu?
Beovu is a drug prescribed to treat wet age-related macular degeneration (AMD). Wet AMD is a chronic eye disorder that causes blurry vision or blind spots. It occurs most commonly in older people with a genetic predisposition to the disorder. While the cause of wet AMD is not known, the vision loss associated with the disorder can be caused abnormal blood vessel growth in the eye or a fluid buildup in the eye. There is no cure for vision already lost to wet AMD.
Drugs like Beovu are in a class of drugs used to prevent future vision loss after a doctor has diagnosed someone with AMD. These drugs, called anti-vascular endothelial growth factor drugs (or anti-VEGF drugs), work by stopping a protein that produces new blood vessels in the eye. When patients receive anti-VEGF treatment, the drugs can stop damage to the eye caused by abnormal vessel growth and slow down vision loss. Besides Beovu, other anti-VEGF drugs on the market include Avastin, Lucentis, and Eylea.
Beovu was approved by the FDA in October 2019 after clinical trials appeared to show its safety. A safety review by Novartis after Beovu was on the market revealed additional side effects not reported to the FDA.
What are the side effects of Beovu?
The newly disclosed side effects of Beovu include retinal vasculitis and retinal vascular occlusion. Retinal vasculitis and retinal vascular occlusion are both disorders that involve impaired blood flow in the eye. Symptoms of retinal vasculitis and retinal vascular occlusion include:
- Sudden change in vision, including a complete or partial loss of vision
- Blurry vision
- Changes in how you see color
- Metamorphopsia, a condition that causes straight lines to look curved
- Blind spots
Both disorders can lead to permanent losses of vision. These side effects do not occur as commonly when patients receive other anti-VEGF treatments, like Eylea, Avastin, and Lucentis.
Has there been a Beovu recall?
The FDA has not yet issued a recall of Beovu. As noted above, the FDA worked with Novartis to update the label of Beovu to include information about the newly known side effects. Beovu otherwise remains on the market. Novartis maintains that the drug is still safe and effective.
Do I have a Beovu case?
Contacting a lawyer is the best way to determine whether you can pursue a Beovu lawsuit against its manufacturers. The experienced lawyers and staff at the Kishish Law Group will listen to your story and guide you through your legal options. If you or a loved one suffered vision loss or blindness after Beovu treatment, you may be entitled to compensation. Contact the Kishish Law Group today for your free and confidential case evaluation by calling us toll free at 1 (888) 609-4664 or by completing our online contact form.
DISCLAIMER: No attorney client relationship will exist between you and our firm until we enter into a signed Retainer/Services Agreement. Completion of this document is for informational purposes only and does not constitute a Retainer/Services Agreement. The information you obtain at this site is not, nor is it intended to be, legal advice. Contacting us does not create an attorney-client relationship. In some jurisdictions this website may be considered lawyer advertising. You should consult an attorney for advice regarding your individual situation. Click here for more information.
Speak with a Beovu Lawyer
If you experienced eye problems including vision loss or blindness after receiving eye treatment with Beovu, you may be entitled to substantial compensation.
Reach out to Kishish Law Group immediately to find out your legal options.
- April 1, 2020
FDA Requests Companies to Stop Selling All Zantac Products, Citing Cancer Concerns
- August 13, 2018
FDA Updates List of Valsartan Blood Pressure Medication Affected by Recall
- February 18, 2018
Invokana Lawsuits Rise, First Trial of Alleged Amputation Set for September
- June 12, 2017
Invokana Side Effects and Diabetic Ketoacidosis
- June 8, 2017
SGLT2 Inhibitors, like Invokana, Found to Double Risk of Diabetic Ketoacidosis